Kyowa

Rediff.com » News » Kyowa

News for Kyowa

Business

Lupin aims to enter Chinese market in the next one year

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time. Mumbai-headquartered Lupin is firming up plans to......

Lupin sells Japan arm to Unison for Rs 3,702 cr

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India. Pharma major Lupin has divested its entire stake in its Japanese subsidiary,......

Lupin to buy 21 products of Japan's Shionogi for Rs 1,000 cr

This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally. Kyowa Pharmaceutical Industry, drug major Lupin's Japanese subsidiary, has......

Lupin buys Japan's Kyowa Pharma

Indian pharma company Lupin has acquired 80 per cent stake in Kyowa Pharmaceutical Industry (Kyowa), one of the top 10 generic pharmaceutical companies in Japan, for an undisclosed amount. Lupin......

Lupin, Kyowa Pharma ink deal

Lupin and Japan's Kyowa Pharmaceutical have entered into agreements through which the two will cooperate to market finished formulations in Japan. According to a release issued by Lupin to the......

Rediff News

Kyowa

News for Kyowa

Lupin aims to enter Chinese market in the next one year

Lupin sells Japan arm to Unison for Rs 3,702 cr

Lupin to buy 21 products of Japan's Shionogi for Rs 1,000 cr

Lupin buys Japan's Kyowa Pharma

Lupin, Kyowa Pharma ink deal

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS